Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Clinical Lung Cancer|July 11, 2024
The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain MetastasesXiancheng Wu, Laura P Stabile, Timothy F Burns
Immunotherapy|July 31, 2019
The estrogen pathway as a modulator of response to immunotherapyMaria A Velez, Timothy F Burns, Laura P Stabile
Experimental Hematology & Oncology|December 18, 2015
Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinomaDiwakar Davar, Mark A Socinski, Sanja Dacic, et al.
Clinical Advances in Hematology & Oncology : H&O|July 6, 2016
HSP90 inhibitors in lung cancer: promise still unfulfilledSuman Chatterjee, Saveri Bhattacharya, Mark A Socinski, et al.
Molecular Cancer Therapeutics|June 2, 2017
Reactivation of the p90RSK-CDC25C Pathway Leads to Bypass of the Ganetespib-Induced G2-M Arrest and Mediates Acquired Resistance to Ganetespib in KRAS-Mutant NSCLCSuman Chatterjee, Eric H-B Huang, Ian Christie, et al.
Scientific Reports|October 9, 2023
Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective studyJingxiao Jin, Jacqueline Visina, Timothy F Burns, et al.
Seminars in Respiratory and Critical Care Medicine|November 22, 2013
Personalizing therapy in advanced non-small cell lung cancerLiza C Villaruz, Timothy F Burns, Vasilis S Ramfidis, et al.
Autophagy|March 22, 2018
HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLCJie Han, Leslie A Goldstein, Wen Hou, et al.
Molecular Cancer Therapeutics|February 8, 2017
Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS-Mutant NSCLC Is Mediated via Reactivation of the ERK-p90RSK-mTOR Signaling NetworkSuman Chatterjee, Eric H-B Huang, Ian Christie, et al.
Molecular and Cellular Biology|August 5, 2003
Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cellsTimothy F Burns, Peiwen Fei, Kimberly A Scata, et al.
Pageof 7